13F Portfolios

SurgoCap Partners LP 13F: Quarter-over-Quarter Portfolio Changes

SurgoCap Partners LP reported a disclosed portfolio value of approximately $3.0 billion in its latest SEC Form 13F-HR filing for Q1 2026, down 17.1% quarter on quarter. Over the quarter, the fund initiated 3 new positions, bought more shares in 6 holdings, trimmed 3 holdings, and exited 6 positions.

SurgoCap Partners LP's top buy was a new stake in Medline INC (MDLN) , equal to 9.0% of the disclosed portfolio. Its top sell was Blackstone (BX) . The fund exited the position completely after it had accounted for 8.9% of the previous portfolio.

New PositionsQ1 2026

Securities disclosed for the first time in Q1 2026 that were not present in the prior 13F-HR filing.

SurgoCap Partners LP new positions in Q1 2026, representing first-time disclosed long equity stakes
CompanyTickerInitial Portfolio WeightHistory
MEDLINE INCMDLN9.0%History →
CORNING INCGLW3.9%History →
VISAV2.9%Holders →

Top BuysQ1 2026

The fund's top buys among existing positions in Q1 2026. Ranked by portfolio-weight impact, with the percentage of additional shares shown separately.

SurgoCap Partners LP top buys in existing positions in Q1 2026
CompanyTickerPortfolio Weight ChangeMore SharesHistory
NVIDIA CORPORATION COMNVDA+2.7%+61.9%History →
SHOPIFY INCSHOP+0.5%+48.1%Holders →
INTUITIVE SURGICAL INCISRG+1.0%+26.7%History →
ALPHABET CL CGOOG+3.4%+19.1%History →
CARPENTER TECHNOLOGY CORPCRS+5.7%+3.8%History →
LPL FINL HLDGS INCLPLA+0.4%+2.6%History →

Top SellsQ1 2026

The fund's top sells among positions it retained in Q1 2026. Ranked by portfolio-weight impact. Full exits are listed separately.

SurgoCap Partners LP top sells in existing positions in Q1 2026
CompanyTickerPortfolio Weight ChangeShares SoldHistory
MCKESSON CORPMCK0.6%16.8%History →
NU HOLDINGS LTDNU-0.1%6.2%History →
TAIWAN SEMIC-ADRTSM3.2%0.1%History →

Full ExitsQ1 2026

Positions present in the prior 13F-HR filing that no longer appear in Q1 2026.

SurgoCap Partners LP full exits in Q1 2026
CompanyTickerLast-Reported Portfolio Weight
BLACKSTONEBX8.9%
BOSTON SCIENTIFIC CORPBSX6.8%
BROADCOMAVGO6.4%
HILTON WORLDWIDE HLDGS INCHLT4.0%
GUIDEWIRE SOFTWARE INCGWRE4.0%
ARMSTRONG WORLD INDS INC NEWAWI2.0%
Latest

Net Portfolio Value ChangeQ1 2026

  • $3.6B
    Prior quarter
  • $3.0B
    Current quarter
  • $-0.6B
    Net delta
  • -17.1%
    % change

Methodology & FAQ

How SurgoCap Partners LP Quarterly Changes Are Computed

All deltas are sourced from sequential SEC Form 13F-HR filings for SurgoCap Partners LP: each row joins the most recent filing against the immediately preceding quarterly filing for the same fund. Share-count changes reflect reported trading activity, while portfolio weights can also move because of market price changes. Portfolio weights are normalized to exclude listed options for comparability. A complete description — including how confidential treatment filings are handled — is documented in the Methodology.

What stocks did SurgoCap Partners LP buy in Q1 2026?

In Q1 2026, SurgoCap Partners LP initiated 3 new positions (MEDLINE INC (MDLN), CORNING INC (GLW), VISA (V)); bought more shares of NVIDIA CORPORATION COM (NVDA), SHOPIFY INC (SHOP), INTUITIVE SURGICAL INC (ISRG), ALPHABET CL C (GOOG), CARPENTER TECHNOLOGY CORP (CRS) — the largest 5 of 6 adds.

What stocks did SurgoCap Partners LP sell in Q1 2026?

In Q1 2026, SurgoCap Partners LP fully sold 6 positions (BLACKSTONE (BX), BOSTON SCIENTIFIC CORP (BSX), BROADCOM (AVGO), HILTON WORLDWIDE HLDGS INC (HLT), GUIDEWIRE SOFTWARE INC (GWRE), ARMSTRONG WORLD INDS INC NEW (AWI)); reduced holdings in MCKESSON CORP (MCK), NU HOLDINGS LTD (NU), TAIWAN SEMIC-ADR (TSM).

Which positions did SurgoCap Partners LP initiate in Q1 2026?

SurgoCap Partners LP established 3 new positions in Q1 2026: MEDLINE INC (MDLN, 9.0%), CORNING INC (GLW, 3.9%), VISA (V, 2.9%).

Which existing positions saw the largest allocation increases for SurgoCap Partners LP in Q1 2026?

Of 6 existing positions with share-count increases in Q1 2026, the largest were: NVIDIA CORPORATION COM (NVDA, +2.7% weight, +61.9% shares), SHOPIFY INC (SHOP, +0.5% weight, +48.1% shares), INTUITIVE SURGICAL INC (ISRG, +1.0% weight, +26.7% shares), ALPHABET CL C (GOOG, +3.4% weight, +19.1% shares), CARPENTER TECHNOLOGY CORP (CRS, +5.7% weight, +3.8% shares), LPL FINL HLDGS INC (LPLA, +0.4% weight, +2.6% shares).

Which positions did SurgoCap Partners LP fully exit in Q1 2026?

SurgoCap Partners LP fully exited 6 positions in Q1 2026: BLACKSTONE (BX, last-reported weight 8.9%), BOSTON SCIENTIFIC CORP (BSX, last-reported weight 6.8%), BROADCOM (AVGO, last-reported weight 6.4%), HILTON WORLDWIDE HLDGS INC (HLT, last-reported weight 4.0%), GUIDEWIRE SOFTWARE INC (GWRE, last-reported weight 4.0%), ARMSTRONG WORLD INDS INC NEW (AWI, last-reported weight 2.0%).

Which existing positions saw the largest allocation reductions for SurgoCap Partners LP in Q1 2026?

Of 3 existing positions with share-count reductions in Q1 2026, the largest were: MCKESSON CORP (MCK, 0.6% weight, -16.8% shares), NU HOLDINGS LTD (NU, -0.1% weight, -6.2% shares), TAIWAN SEMIC-ADR (TSM, 3.2% weight, -0.1% shares).

Do quarter-over-quarter 13F allocation changes constitute explicit trading signals?

No. Quarter-over-quarter changes reflect a combination of active trading and market price movement. A weight increase can result from price appreciation alone, without the manager adding shares. Share-count delta is the cleaner indicator of explicit trading activity. All deltas on this page are sourced from sequential SEC Form 13F-HR filings.